Effects of Modified Sanhuang Decoction (加味三黄汤) enema on serum tumor necrosis factor-α and colonic mucosa interleukin-1β, interleukin-6 levels in ulcerative colitis rats

Chinese Journal of Integrative Medicine

Volumn 20, Issue 11, 2014, Pages 865-869

  Wang, Shuai ^a   Zhou, Tao ^a   Zhai, Jun peng ^a   Wang, Li hua ^b   Chen, Jing ^a  

^a BEIJING HOSPITAL OF TRADITIONAL CHINESE MEDICINE AFFILIATED TO CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Institute of Chinese Medicine   (China)

Author keywords

Chinese herbal therapy; interleukin 1 ; interleukin 6; tumor necrosis factor ; ulcerative colitis

Indexed keywords

ENEMA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MODIFIED SANHUANG DECOCTION; SALAZOSULFAPYRIDINE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HERBACEOUS AGENT; SANHUANG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; MALE; NONHUMAN; RADIOIMMUNOASSAY; RAT; ULCER; ULCERATIVE COLITIS; ANIMAL; BLOOD; COLITIS, ULCERATIVE; COLON; INTESTINE MUCOSA; METABOLISM; WISTAR RAT;

ANIMALS; COLITIS, ULCERATIVE; COLON; DRUGS, CHINESE HERBAL; ENEMA; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; RATS; RATS, WISTAR;

EID: 84905059210     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-013-1538-z     Document Type: Article

References (20)

1. Ooi CJ, Fock KM, Makharia GK, Goh KL, Ling KL, Hilmi I, et al. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol 2010;25:453–468.
2. Jun CD, Kim Y, Choi EY, Kim M, Park B, Youn B, et al. Gliotoxin reduces the severity of trinitrobenzene sulfonic acidinduced colitis in mice: evidence of the connection between heme oxygenase-1 and the nuclear factor-kappaB pathway in vitro and in vivo. Inflamm Bowel Dis 2006;12:619–629.
3. Cheon JH, Kim JS, Kim JM, Kim N, Jung HC, Song IS, et al. Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking Ikappa B kinase and ameliorates acute murine colitis. Inflamm Bowel Dis 2006;12:1152–1161.
4. Cao YB, Zhang JD, Diao YY, Yan L, Wang DJ, Jia XM, et al. Effects of Changtai Granules, a traditional compound Chinese medicine, on chronic trinitrobenzene sulfonic acid-induced colitis in rats. World J Gastroenterol 2005;11:3539–3543.
5. Butzner JD, Parmar R, Bell CJ, Dalal V. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 1996;38:568–573.
6. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Peña AS, Meuwissen SG, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immuno 1998;114:385–391.
7. Fidler JM. Induction of hapten-specific immunological tolerance and immunity in B lymphocytes. VII. Correlation between trinitrobezenesulfonic acid administration, serum trinitrophenyl content, and level of tolerance. Cell Immuno 1985;94:285–291.
8. Little JR, Eisen HN. Preparation and charaterization of antibodies specific for the 2,4,6-trinitriphenyl group. Biochemistry 1966;5:3385–3395.
9. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577–594.
10. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995;154:2434–2440.
11. Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T, et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn’s disease. Clin Exp Immunol 1994;96:432–436.
12. Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 1998;42:470–476.
13. Nam SY, Kim JS, Kim JM, Lee JY, Kim N, Jung HC, et al. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis. Exp Biol Med (Maywood) 2008;233:180–191.
14. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 1998;115:297–306.
15. Reinecker HC, Steffen M, Witthoeft T, Pflueqer I, Schreiber S, MacDermott RP, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with UC and Crohn’s disease. Clin Exp Immunol 1993;94:174–181.
16. León AJ, Gómez E, Garrote JA, Bernardo D, Barrera A, Marcos JL, et al. High level of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD. Mediators Inflamm 2009;2009:580450.
17. Tahan G, Aytac E, Aytekin H, Gunduz F, Dogusoy G, Aydin S, et al. Vitamin E has a dual effect of anti-inflammatory and antioxidant activities in acetic acid-induced ulcerative colitis in rats. Can J Surg 2011;54:333–338.
18. Pamuk GE, Vural O, Turgut B, Demir M, Umit H, Tezel A. Increased circulating platelet-neutrophil, plateletmonocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Am J Hematol 2006;81:753–759.
19. Irving PM, Macey MG, Feakins RM, Knowles CH, Frye JN, Liyanage SH, et al. Platelet-leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2008;20:283–289.
20. Polińska B, Matowicka-Karna J, Kemona H. Assessment of the influence of the inflammatory process on the activation of blood platelets and morphological parameters in patients with ulcerative colitis (colitis ulcerosa). Folia Histochem cytobiol 2011;49:119–124.